TWA
ABBV icon

Tulsa Wealth Advisors’s AbbVie ABBV Stock Holding History

Tulsa Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.87M Buy
19,352
+1,191
+7% +$256K 0.69% 29
2026
Q1 		$3.95M Sell
18,161
-7,155
-28% -$1.59M 0.69% 30
2025
Q4 		$5.78M Buy
+25,316
New +$5.77M 1.92% 16

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Tulsa Wealth Advisors's ABBV Position: Q2 2026 in Review

Tulsa Wealth Advisors increased its AbbVie (ABBV) stake by 6.6% in Q2 2026, buying an estimated $256K and bringing the position to 19,352 shares worth $4.87M. The position accounts for 0.69% of the portfolio, ranked #29.

Tulsa Wealth Advisors first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. The position peaked at $5.78M in Q4 2025. 4,194 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Tulsa Wealth Advisors held 19,352 shares of AbbVie worth $4.87M as of Q2 2026.
  • Tulsa Wealth Advisors bought 1,191 AbbVie shares in Q2 2026, an estimated $256K.
  • AbbVie made up 0.69% of Tulsa Wealth Advisors's portfolio in Q2 2026, its #29 holding.
  • Tulsa Wealth Advisors first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
  • Tulsa Wealth Advisors's AbbVie position peaked at $5.78M in Q4 2025.
  • 4,194 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Tulsa Wealth Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.